HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

WELLS FARGO & COMPANY/MN's Holding History (CIK: 0000072971)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,446,000 Value ($000) $1,567 Avg Close — Range —
Q3 2025
Shares 1,463,000 Value ($000) $1,690 Avg Close — Range —
Q2 2025
Shares 2,738,000 Value ($000) $2,728 Avg Close — Range —
Q1 2025
Shares 8,480,000 Value ($000) $9,005 Avg Close — Range —
Q4 2024
Shares 6,546,000 Value ($000) $6,248 Avg Close — Range —
Q3 2024
Shares 4,675,000 Value ($000) $4,690 Avg Close — Range —
Q2 2024
Shares 14,737,000 Value ($000) $14,029 Avg Close — Range —
Q1 2024
Shares 15,399,000 Value ($000) $13,670 Avg Close — Range —
Q4 2023
Shares 14,925,000 Value ($000) $12,878 Avg Close — Range —
Q3 2023
Shares 14,391,000 Value ($000) $12,198 Avg Close — Range —
Q2 2023
Shares 10,099,000 Value ($000) $8,411 Avg Close — Range —
Q1 2023
Shares 3,207,000 Value ($000) $2,719 Avg Close — Range —
Q4 2022
Shares 1,978,000 Value ($000) $1,925 Avg Close — Range —
Q3 2022
Shares 978,000 Value ($000) $834 Avg Close — Range —
Q2 2022
Shares 828,000 Value ($000) $737 Avg Close — Range —
Q1 2022
Shares 1,828,000 Value ($000) $1,603 Avg Close — Range —